Survey
Please enter the number of persons (including yourself) who will be viewing this activity:
Your Degree (select all that apply)
Select degree
MD
DO
RN
NP
PA
DDS
PhT
CPhT
PharmD
RPh
DMD
Allied Healthcare Professional - CCMC
PhD
LPN
OD
Allied Healthcare Professional - LPC
Allied Healthcare Professional - NCC
Allied Healthcare Professional - Psychology
Allied Healthcare Professional - SW
Allied Healthcare Professional - Other
Your area of clinical practice (select all that apply)
Select area of clinical practice
Addiction
Allergy/Clinical Immunology
Anesthesiology
Cardiology
Child and Adolescent Psychiatry
Critical Care/Intensive Care
Dentistry
Dermatology
Emergency Medicine
Endocrinology
Family Medicine
Gastroenterology
General Practice
Geriatrics
Hematology/Oncology
Hospitalist
Infectious Diseases
Internal Medicine
Neonatal/Perinatal Medicine
Nephrology
Neurology
Nutrition
Obstetrics/Gynecology
Ophthalmology
Optometry
Orthopaedics
Osteopathy
Otolaryngology
Pain Specialist
Pediatrics
Pharmacy
Pharmacy Technician
Physical Medicine and Rehabilitation
Podiatry
Preventive Medicine
Primary Care Provider
Psychiatry
Pulmonary Medicine
Rheumatology
Sleep Specialist
Sports Medicine
Surgery
Urology
Your practice setting:
Academic Center
Community Pharmacy Practice
Group Practice - Small (less than 5)
Group Practice - Large (5 or more)
Hospital/Institution
Managed Care
Non-Direct Patient Care
Solo Practice
other
Please select the number of years you have been in Practice:
Less than 1
1-5
6-10
11-20
More than 20
On average, how many patients do you see during a month?
0
less than 50
50 to 100
100 to 200
200 to 300
more than 300
On average, how many patients do you see during a month with immune checkpoint inhibitor cardiotoxicity?
0
1 to 5
6 to 10
11 to 15
16 to 20
21 to 25
26 to 49
more than 50
Assess and rate your competence in the diagnosis and treatment of immune checkpoint inhibitor cardiotoxicity.
1 = not competent.
5 = average competence.
10 = exceptionally competent.
Based on your observations, where are the common gaps and challenges in knowledge, competence, or practice that clinicians face in the area of immune checkpoint inhibitor cardiotoxicity?
Continue